Diagnostic Approach to Mastitis in Small Ruminants: Clinical and Subclinical

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Small ruminant mastitis diagnostics necessitate species-specific interpretation, particularly for somatic cell counts (SCC) and California Mastitis Test (CMT) results, as goats have higher baseline SCC due to apocrine secretion and normal shedding of epithelial cells, unlike sheep.
• Staphylococcus aureus is a primary pathogen for clinical mastitis in sheep and goats, with ovine and caprine isolates exhibiting genetic distinctiveness from bovine strains, potentially impacting diagnostic assay reliability and control strategies.
• Subclinical mastitis, often caused by coagulase-negative staphylococci or S. aureus, is detected via SCC and CMT, requiring bacteriological confirmation; composite milk samples can dilute low-grade infections, making gland-specific sampling preferable for individual animal management.
• Aseptic milk sampling is critical and must precede any antimicrobial administration to ensure accurate culture results, with common diagnostic errors including post-treatment sampling, pooling of samples from multiple glands, and misinterpretation of SCC without species-specific reference values.
• Mycoplasma species, particularly M. agalactiae, require specialized culture media and notification to the laboratory, and molecular methods like PCR can offer rapid identification but may not detect all ovine/caprine S. aureus strains due to genetic diversity.
• Differential diagnoses for udder abnormalities include trauma, teat obstruction, abscess, and neoplasia, which are distinguished from mastitis through cytology, culture, and potentially ultrasonography, with gangrenous mastitis often associated with Mannheimia hemolytica in sheep.

Mastitis in sheep and goats is a production-limiting disease with distinct diagnostic challenges compared with dairy cattle. This article provides a structured diagnostic approach for the practicing veterinarian, covering both clinical and subclinical forms of intramammary infection in small ruminants. The content addresses pathogen recognition, sampling technique, laboratory interpretation, and the diagnostic reasoning that distinguishes mastitis from other causes of udder abnormality or milk quality failure.

The reader is assumed to be a qualified veterinarian with working knowledge of ruminant medicine and routine laboratory interpretation. The article does not cover treatment or control programs, but the diagnostic decisions described here directly inform those subsequent choices. Where the evidence base is drawn largely from bovine research, this is stated explicitly, because extrapolation from cattle to small ruminants carries real limitations.

At a Glance

Pathogen Biology and Host Specificity

The microbiology of small ruminant mastitis differs from bovine mastitis in several clinically relevant ways. Staphylococcus aureus is recognized worldwide as a major cause of clinical and subclinical intramammary infection in lactating sheep and goats, and it is also the pathogen most frequently associated with clinical disease in these species. Genomic studies have demonstrated that ovine and caprine isolates are genetically allied to each other but distinct from bovine isolates, with host-specific virulence gene profiles that may influence both pathogenicity and diagnostic test performance. The presence of lineage- and host-specific genes in small ruminant isolates suggests that diagnostic assays developed for bovine strains may not detect all ovine or caprine infections reliably.

Coagulase-negative staphylococci are the most common isolates from subclinical infections in both species, although their clinical significance is often marginal. Mannheimia hemolytica causes a peracute, often gangrenous mastitis in sheep, particularly in ewes with lambs at foot. Mycoplasma species, especially M. agalactiae, are regionally important and require special culture media. The distribution of pathogens varies by production system, region, and stage of lactation, so the diagnostic plan should be adjusted accordingly.

Clinical Mastitis: Recognition and Initial Assessment

Clinical mastitis in small ruminants presents on a spectrum from mild milk abnormality to peracute gangrenous disease. The affected gland may be swollen, firm, hot, or painful, and the milk may contain clots, blood, or a watery appearance. Systemic signs such as fever, anorexia, and recumbency indicate severe disease and warrant immediate diagnostic sampling before any intervention.

The physical examination should include both glands, assessment of the supramammary lymph nodes, and evaluation of the udder for wounds, teat lesions, or evidence of contagious ecthyma. In sheep, the contralateral gland should be examined carefully because bilateral disease is common in peracute M. hemolytica infection. In goats, the two halves of the udder are anatomically separate, and infection in one gland does not imply involvement of the other.

Aseptic milk sampling is the central element of diagnosis. The teat end should be cleaned with chlorhexidine or alcohol, the first streams discarded, and the sample collected into a sterile container. The sample must be obtained before any antimicrobial therapy is administered, because prior treatment markedly reduces culture sensitivity. For gangrenous mastitis, samples from the viable tissue margin may be more informative than samples from necrotic tissue.

Subclinical Mastitis: Detection and Sampling Strategy

Subclinical mastitis produces no visible abnormality of the gland or milk, yet it accounts for the majority of production loss and serves as the reservoir for clinical outbreaks. Detection relies on indirect indicators of inflammation followed by bacteriological confirmation.

The somatic cell count (SCC) is the most widely used screening test, but interpretation differs between species. Sheep have a low physiological SCC, and thresholds for subclinical infection are correspondingly lower than in cattle. Goats present a particular problem because normal milk contains cytoplasmic particles and cell fragments that elevate the SCC in the absence of infection, and the cell count also rises with stage of lactation and estrus. The California Mastitis Test (CMT) can be used as a cow-side screening tool, but its positive predictive value in goats is lower than in sheep, and a positive result should prompt bacteriological sampling instead of treatment.

Bacteriological culture remains the reference standard for diagnosis of subclinical infection. Composite samples from both glands are convenient but can dilute a low-grade infection in one gland below the limit of detection. Gland-specific samples are preferred when the goal is to identify infected individuals for culling or segregation. Bulk tank milk culture is useful for herd-level surveillance, particularly for S. aureus and Mycoplasma species, but it cannot identify individual infected animals.

Laboratory Testing and Interpretation

Culture media selection depends on the pathogens suspected. Blood agar supports growth of most common pathogens, and MacConkey agar should be included if gram-negative organizms are possible. Mycoplasma species require specialized media and prolonged incubation, so the laboratory should be notified when this pathogen is suspected. Antimicrobial susceptibility testing is recommended to direct treatment decisions in many clinical settings, although the evidence that susceptibility predicts treatment outcome for intramammary infections is limited, and this limitation applies to small ruminants as much as to dairy cattle.

Molecular methods, including PCR-based assays, offer faster species identification and can detect pathogens that are difficult to culture. However, these assays may not detect all strains of S. aureus from small ruminants because of the genetic diversity described above. The diagnostic laboratory should be asked about the validation of its assays for ovine and caprine samples.

Differential Diagnosis and Diagnostic Errors

The differential diagnosis for udder swelling or milk abnormality includes trauma, teat obstruction, abscess, and neoplasia. Trauma is common in intensively managed goats and may produce hematoma or seroma without infection. Teat obstruction from fibrosis or calculi can cause milk retention and secondary inflammation. These conditions are distinguished from mastitis by cytology and culture of milk, and by ultrasonography where available.

The most common diagnostic errors are sampling after antimicrobial treatment has begun, pooling samples from multiple glands, and interpreting SCC without species-specific reference values. Each of these errors leads to false-negative results and misdirected control decisions. The veterinarian should confirm the sampling technique with farm staff and ensure that samples reach the laboratory promptly, because delayed transport allows overgrowth of contaminants and loss of fastidious pathogens.

Diagnostic Sequence for Clinical Mastitis

The investigation of clinical mastitis in sheep and goats should follow a structured sequence that begins with the individual animal and expands to the group when patterns emerge. For the individual case, the first decision is whether the presentation is peracute, acute, or chronic, because this determines the urgency of sampling and the likelihood of systemic involvement.

Peracute mastitis presents with a depressed ewe or doe, fever, reduced rumen motility, and a swollen, discoloured, or cold udder. The affected half may be gangrenous, and the animal may be recumbent or reluctant to move. In this setting, collect an aseptic milk sample before starting any antimicrobial therapy, then proceed with supportive care. The sample should be refrigerated and submitted for culture within 24 hours. Gram staining of a direct smear can provide immediate guidance, particularly when clostridial or staphylococcal infection is suspected.

Acute mastitis presents with local signs: heat, swelling, pain, and abnormal milk. The animal is usually systemically stable. Sample the affected half aseptically, record the gross appearance of the milk, and examine the udder for wounds, teat lesions, or evidence of trauma. Chronic mastitis presents with persistent abnormalities in milk quality, often with palpable fibrosis or abscessation of the gland. These cases may have been treated previously, and culture results from earlier episodes, if available, should inform the current sampling plan.

The clinical examination should include assessment of both halves, because bilateral infection is common in small ruminants. Palpate the supramammary lymph nodes, enlargement is expected with chronic infection but marked asymmetry warrants biopsy if neoplasia is considered. Note the color and consistency of the milk, the presence of clots, and any odour. Gangrenous mastitis produces a dark, watery, foul-smelling discharge and requires immediate attention to the animal's systemic status.

California Mastitis Test and Somatic Cell Count Interpretation

The California Mastitis Test (CMT) is the most practical cow-side screening tool for subclinical mastitis in small ruminants. The test detects DNA in somatic cells, primarily leukocytes, and produces a gel-like reaction that is graded from negative to 3+. Interpretation differs between sheep and goats because goats normally have higher somatic cell counts, partly due to apocrine secretion and the presence of cytoplasmic particles in milk.

In goats, a single elevated CMT score is less specific than in sheep. The test is best used as a screening tool at the flock or herd level, with positive animals confirmed by bacteriological culture. The MSD Veterinary Manual provides species-specific guidance on milk quality testing and interpretation of somatic cell counts in small ruminants.

Somatic cell count thresholds for subclinical mastitis are generally lower in sheep than in goats. A threshold of 250,000 cells per mL is commonly used for sheep, while goats may require a threshold of 750,000 cells per mL or higher, particularly in early lactation or when the doe is in high production. Individual animal variation is substantial in goats, so serial sampling is more informative than a single measurement.

Aseptic Milk Collection Technique

The quality of the diagnostic sample determines the reliability of culture results. Collect milk samples before any antimicrobial administration. For the individual animal, clean the teat end with 70% alcohol, allow it to dry, discard the first three streams of milk, and collect the sample into a sterile tube. Wear gloves and avoid touching the teat end after disinfection.

For flock-level investigation, collect samples from a representative number of animals. The number depends on the prevalence of subclinical infection and the purpose of the investigation. For a herd screen, sample 10 to 20 animals per management group, prioritizing animals with elevated CMT scores, history of clinical mastitis, or high somatic cell counts from recording data. FAO technical guidance on livestock production systems emphasizes the importance of sampling strategy in disease investigation, particularly when prevalence is low.

Refrigerate samples immediately and transport them to the laboratory within 24 hours. If transport is delayed, freeze the samples at minus 20 degrees Celsius, but note that freezing reduces the viability of some pathogens, particularly Gram-negative organizms. For polymerase chain reaction (PCR) testing, freezing is acceptable and may even improve DNA extraction efficiency.

Culture and Pathogen Identification

Bacteriological culture remains the reference standard for mastitis diagnosis in small ruminants. Inoculate the sample onto sheep blood agar and MacConkey agar, and incubate aerobically at 35 to 37 degrees Celsius for 24 to 48 hours. Staphylococcus aureus is the most frequently isolated pathogen from clinical mastitis in sheep and goats, and its identification should include coagulase testing and, where available, molecular typing.

The genetic diversity of S. aureus isolates from small ruminants is well documented. Ovine and caprine isolates are often closely related and may differ from bovine isolates in virulence gene content and clonal complex assignment. Studies using DNA microarray and whole-genome approaches have demonstrated host-specific genetic loci in ruminant isolates, with ovine and caprine strains frequently assigned to clonal complexes such as CC130 and CC133. These findings have practical implications: the epidemiology of S. aureus mastitis in sheep and goats may differ from that in cattle, and control measures developed for dairy herds may not transfer directly to small ruminant flocks. The genomic analysis of ruminant Staphylococcus aureus and the comparison of isolates from goat and sheep milk both support this host-specific variation.

Coagulase-negative staphylococci are common isolates from subclinical mastitis in small ruminants, particularly in goats. Their clinical significance is debated, but heavy growth in pure culture from a gland with elevated somatic cell count is likely to be significant. Mannheimia hemolytica, Pasteurella multocida, and Trueperella pyogenes are important causes of clinical mastitis, particularly in ewes. Gram-negative isolates should be identified to species level where possible, because treatment and prognosis differ.

Antimicrobial Susceptibility Testing

Susceptibility testing is recommended for cases that fail to respond to initial therapy, for recurrent mastitis, and for flock-level outbreaks where treatment failure is suspected. The multispecies review of mastitis therapy and antimicrobial susceptibility notes that the value of susceptibility testing for predicting treatment outcome in mastitis has been challenged, particularly in dairy cattle. The same caution applies to small ruminants, where the evidence base is even more limited.

Interpret susceptibility results with knowledge of the pharmacokinetics of the drug in the target species. A drug that is active in vitro may fail in vivo because of poor penetration into the mammary gland, protein binding, or the presence of abscesses. Conversely, a drug that appears resistant in vitro may be clinically effective at high concentrations in milk. The review of cephalosporin use in food animals illustrates the importance of understanding drug distribution and metabolism when selecting antimicrobial therapy for mastitis.

For small ruminants, the choice of antimicrobial should consider the species, the production system, and the withdrawal period requirements for milk and meat. Current formulary and label references must be consulted before prescribing, because approved products and withdrawal periods vary between countries and regions. The WOAH terrestrial animal health standards provide international guidance on responsible antimicrobial use in food-producing animals.

Documentation and Flock-Level Pattern Recognition

Record every mastitis case with the following data: animal identification, date, affected half, clinical severity score, CMT result, culture result, and susceptibility profile if performed. Maintain a treatment log that includes the drug used, dose, route, duration, and outcome. This documentation supports pattern recognition at the flock level and informs future treatment decisions.

When multiple cases occur within a short period, investigate common risk factors. Review bedding, milking hygiene, teat condition, and the milking routine. Check the milking machine if one is used, including vacuum levels and pulsation rates. Examine the environment for sources of contamination, particularly in lambing or kidding areas. The USDA APHIS animal health information and the AVMA practice resources provide frameworks for investigating disease outbreaks in livestock production systems.

A diagnostic checklist for mastitis in small ruminants should include the following elements: aseptic milk collection before antimicrobial therapy, CMT screening of all lactating animals, culture of all clinical cases, susceptibility testing for treatment failures, and systematic recording of clinical and laboratory findings. This checklist applies to both sheep and goats, but the interpretation of CMT results and somatic cell counts must be adjusted for species, as described above.

Complications and Failure Modes

Mastitis in small ruminants can progress through several recognized complications that alter both prognosis and diagnostic interpretation. Gangrenous mastitis, most often associated with Staphylococcus aureus or Clostridium perfringens, presents with cold, blue-black teat and udder tissue, systemic toxemia, and a characteriztic line of demarcation between viable and necrotic tissue. Early detection depends on daily udder inspection during the periparturient period, because the transition from local inflammation to necrosis can occur within hours. Merz and colleagues describe S. aureus as the main cause of clinical mastitis in small ruminants, and the same organizm accounts for most gangrenous presentations.

Chronic abscessation represents a second failure mode. Fibrous capsules wall off infection, producing palpable nodules that may not shed organizms into milk consistently. Repeated culture from such udders yields intermittent false negatives, and the clinician should correlate ultrasonographic findings with culture results instead of relying on a single negative sample. Genomic studies of ruminant S. aureus isolates have demonstrated host-specific genetic loci, which may explain why some strains persist in the udder while others are cleared spontaneously.

Septicemia and death occur most frequently in does and ewes with periparturient mastitis, particularly when Mannheimia hemolytica or Escherichia coli is involved. Pyrexia, recumbency, and reduced rumen motility precede visible udder changes in some animals, so a complete clinical examination instead of udder palpation alone is required for early recognition.

Common Diagnostic Errors

Less experienced clinicians commonly misinterpret a single negative culture as proof that infection is absent. The sensitivity of one culture from a subclinically infected gland is imperfect, particularly when organizms are shed intermittently or when the sample was frozen before plating. Barlow's review of mastitis therapy notes that antimicrobial susceptibility testing is recommended in many clinical settings, but the same review acknowledges that susceptibility results do not always predict treatment outcome. A negative culture should prompt repeat sampling instead of a diagnosis of non-infectious inflammation.

A second recurring error is the failure to distinguish teat lesions from intramammary infection. Vesicles, scabs, or traumatic injuries at the teat end can elevate SCC and produce false-positive California Mastitis Test results without true gland infection. Careful examination of the teat skin and orifice before milk sampling prevents this misclassification.

A third error involves pooling samples from both glands. Each gland must be sampled and interpreted separately, because unilateral infection is the rule in most small ruminant mastitis cases. Pooling dilutes the infected gland's contribution and can obscure a high SCC or a positive culture.

Evidence Limitations and Divergent Expert Opinion

The evidence base for small ruminant mastitis diagnostics is thinner than for dairy cattle. Barlow's multispecies review observes that research on mastitis treatment in sheep and goats has been less frequent than in cattle, and the same gap applies to diagnostic validation. Somatic cell count thresholds for subclinical mastitis in sheep and goats remain contested. Goat milk contains cytoplasmic particles and apocrine secretions that can elevate SCC without infection, and the caprine gland normally sheds epithelial cells throughout lactation. Some laboratories apply bovine thresholds to ovine and caprine samples, a practice that overestimates subclinical mastitis prevalence in goats.

Expert opinion also diverges on the value of routine antimicrobial susceptibility testing for small ruminant mastitis isolates. One position holds that susceptibility testing should guide therapy for every clinical case. Another position, supported by the bovine literature, argues that susceptibility results correlate poorly with intramammary treatment outcome because drug penetration, host immunity, and biofilm formation matter more than in vitro inhibition. The review by Barlow summarizes publications that challenge the use of susceptibility testing for antibiotic selection in bovine mastitis. For small ruminants, the clinician should request susceptibility testing for recurrent or severe cases and for herd outbreaks, but should interpret results alongside clinical response.

Referral, Specialist Consultation, and Regulatory Reporting

Most clinical mastitis cases in sheep and goats can be managed in ambulatory practice. Referral or specialist consultation is warranted when gangrenous mastitis requires surgical debridement, when mastitis recurs in the same gland despite appropriate therapy, when a herd outbreak produces more than 10 percent of lactating animals affected within a month, or when the clinician suspects a notifiable or emerging pathogen. Diagnostic laboratories should be consulted before submitting samples for Mycoplasma culture or molecular typing, because transport media and temperature requirements differ from routine bacteriology.

Regulatory reporting obligations vary by jurisdiction. The World Organization for Animal Health publishes terrestrial animal health standards that define which diseases require notification, and USDA APHIS provides national livestock disease information for the United States. Clinicians should confirm local requirements before assuming that a mastitis case carries no reporting obligation. Anthrax can present as peracute mastitis with udder edema in some regions, and any sudden death in a lactating ewe or doe with udder swelling warrants exclusion of notifiable disease before necropsy.

Frequently Asked Questions

How Should I Prioritize Diagnostics When Laboratory Access Is Limited or Cost-Prohibitive?

When culture and cytology are unavailable, prioritize the California Mastitis Test (CMT) or somatic cell count (SCC) to identify affected glands, then pool samples from high-SCC glands for a single culture submission. Clinical mastitis cases warrant individual gland sampling before any antimicrobial administration. If only one culture per flock is affordable, sample the most acute clinical case and one chronic subclinical case. The CMT remains a reliable field screening tool when interpreted alongside palpation and milk appearance. For herds with recurrent mastitis, investing in a single bulk tank culture often provides more actionable information than multiple individual cultures. Reference laboratory submission guides, such as those from USDA APHIS, can help prioritize samples when resources are constrained.

What Is the Minimum Equipment Needed for Reliable Aseptic Milk Collection?

Sterile collection requires only 70% isopropyl alcohol swabs, sterile sample tubes, and single-use gloves. Clip the teat end hair, scrub the teat orifice with alcohol, discard the first three streams, and collect mid-stream milk without touching the tube rim. If sterile tubes are unavailable, boiled glass vials with tight lids can substitute, but contamination risk rises. Samples must chill immediately and reach the laboratory within 48 hours, freezing alters bacterial viability and should be avoided unless culture is delayed beyond 72 hours. For goat herds, collect separate samples from each gland because caprine intramammary infections frequently involve only one side. The MSD Veterinary Manual provides additional guidance on sample handling for small ruminant milk specimens.

How Does the Diagnostic Approach Differ Between Sheep and Goats?

Goats produce milk apically instead of from a single cistern, so foremilk samples more accurately reflect gland health than in sheep. Goat milk also has a higher baseline somatic cell count, particularly during estrus or late lactation, which complicates SCC threshold interpretation. Sheep are more likely to present with gangrenous mastitis caused by Mannheimia hemolytica, whereas goats more often develop chronic subclinical Staphylococcus aureus infections. S. aureus isolates from sheep and goats are genetically allied but distinct from bovine strains, which may influence diagnostic test performance and interpretation Staphylococcus aureus isolates from goat and sheep milk appear closely related and differ from bovine milk isolates. Palpation findings carry more diagnostic weight in goats because udder asymmetry and fibrosis are common even with mild inflammation.

What Records Should I Maintain for Longitudinal Mastitis Monitoring?

Record each sampled gland's CMT score, culture result, and antimicrobial susceptibility pattern by animal identification and lactation number. Note the collection date, clinical status, and any prior treatments within the current lactation. Maintain a flock-level log of monthly bulk tank SCC or CMT prevalence to detect seasonal or management-associated trends. Document the proportion of glands infected with each pathogen species, as this drives control decisions. For certified organic or export-oriented flocks, verify that sampling protocols align with WOAH terrestrial animal health standards for residue avoidance and disease surveillance. These records also support antimicrobial stewardship reviews and help identify chronic shedders that warrant culling instead of repeated treatment.

How Should I Explain Mastitis Test Results to a Producer?

Frame results in terms of production impact and culling decisions instead of laboratory values alone. Explain that a CMT score of 2 or 3 indicates significant inflammation and likely milk loss, while a negative culture with elevated SCC suggests resolving infection or a nonbacterial cause. For S. aureus infections, emphasize that cure rates are low and that the primary goal is preventing spread to other glands and animals. Use the bulk tank culture to illustrate herd-level contamination and the need for milking order changes or teat disinfection. Provide a written summary that lists each positive animal, the pathogen identified, and a recommended action. The AVMA practice resources offer templates for client communication that can be adapted to mastitis discussions.

When Should I Repeat Cultures or Perform Additional Testing After an Initial Negative Result?

Repeat culture within 7 to 14 days when clinical signs persist despite a negative initial culture, as intermittent shedding occurs with S. aureus and some coagulase-negative staphylococci. A second negative culture with persistent CMT elevation warrants cytology to differentiate true infection from sterile inflammation or teat canal damage. For goats, repeat sampling is particularly important because shedding is more intermittent than in sheep. If repeated cultures remain negative but SCC stays elevated, consider mycoplasma or yeast infection, which require specialized culture media. Submit paired acute and convalescent samples when a novel or highly pathogenic organizm is suspected. Antimicrobial susceptibility testing is most valuable when the same pathogen is isolated on consecutive samplings Mastitis therapy and antimicrobial susceptibility review.

Related Clinical & Scientific Guides

• Rumen Health Assessment in Dairy Cows: Clinical and Subclinical Indicators
• Mastitis Control Programs in Dairy Herds: Monitoring and Prevention
• Swine Nutrition and Health: Feed-Related Disease Diagnosis

References and Further Reading

• Mastitis therapy and antimicrobial susceptibility: a multispecies review with a focus on antibiotic treatment of mastitis in dairy cattle.. 2011.
• Genetic differences among Staphylococcus aureus isolates from dairy ruminant species: a single-dye DNA microarray approach.. 2009.
• Cephalosporins in veterinary medicine - ceftiofur use in food animals.. 2002.
• Staphylococcus aureus Isolates from Goat and Sheep Milk Seem to Be Closely Related and Differ from Isolates Detected from Bovine Milk.. 2016.
• Genome-wide analysis of ruminant Staphylococcus aureus reveals diversification of the core genome.. 2008.
• Characterization of Staphylococcus aureus isolates from buffalo, bovine, ovine, and caprine milk samples collected in Rio de Janeiro State, Brazil.. 2007.
• USDA APHIS Animal Health Information. USDA APHIS.
• FAO Animal Production and Health. FAO.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Diagnostic Approach to Respiratory Disease in Sheep and Goats
• Sheep Flock Health: Diagnostic Approach to Lameness
• Diagnostic Approach to Lameness in Sheep: Differentiating Footrot from Other Causes
• Rumen Acidosis in Small Ruminants: Diagnostic Criteria and Differential Diagnosis
• Diagnostic Approach to Mastitis in Dairy Cows: Pathogen Identification and Herd Patterns

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.